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Abstract: Cerebellar liponeurocytoma (LNC) is a very rare neuroepithelial tumor. About 
thirty eight cases have been reported, in literature till date, mostly in the form of isolated 
case reports due to rarity of the occurrence. Authors report interesting case in 27-year 
old male presented with headache and cerebellar signs. MRI imaging revealed posterior 
fossa mass. He underwent sub occipital ctraniectomy with gross total resection of lesion. 
Histopathological report of specimen was consistent with liponeurocytoma with range 
of MIb index   less than three. He is under regular follow-up. However he was not advised 
any adjuvant therapy. Diagnosis of LNC requires high index of suspicion and 
neuroimaging with typical MRI findings may be help to confirm the diagnosis. The 
tumor needs to be differentiated from medulloblastoma, which is far more common and 
aggressive and requires post-operative chemo-radiation and carries poor prognosis   
Management and pertinent literature will be reviewed.  
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Introduction 
Liponeurocytoma is a rare neuroepithelial 
neoplasm involving cerebellum usually seen in 
adult population.       These tumors are slow-
growing, runs indolent course.    Anatomically    
cerebellar hemispheres are commonly   
involved, but may have epicentre   in the 
paramedian region or even vermis (1).  It is   
typically well circumscribed and does not 
infiltrate surrounding neural tissue, however, 
may show pressure effect on adjoining 
anatomical structure, with progress in the size 
of lesion cause pressure and distortion over 
fourth ventricle leading to blockage of CSF 
pathway with development of obstructive 
hydrocephalus. The patient initially   presents 
with cerebellar signs and as lesion progresses 
features of raised intracranial pressure also 
appears. It runs favourable course and surgical 
management is treatment of choice. It needs to 
be differentiated from medulloblastoma, 
where surgical treatments followed by 
adjuvant chemotherapy constitute an integral 
part of management due to aggressive 
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biological behaviour. Microscopically it 
consists of neurocytic cells with focal areas of 
differentiated cells   resembling mature 
adipose tissue (2). 
Case report  
A 27-year old male presented with 
complaints progressive continuous headache   
associated intermittent vomiting   for four 
months. He also noticed imbalance while 
walking two months back prior to admission.  
For 3 months and gait imbalance for 2 months. 
Patient did not give any history of systemic 
complaints on examination. There was no 
history of any co-morbidity. Visual acuity was 
normal funfi examination showed bilateral 
papilloedema, had bilateral cerebellar signs 
more prominent on left side, and rest of the 
neurological examination were within normal 
limit. Routine hematological and biochemical 
investigations were within normal limits.   
Non contrast computed tomogram 
(NCCT) scan of head revealed hypodense 
lesion in midline posteror to fourth ventricle 
with obstructive hydrocephalus (Figure 1).   
Magnetic resonance imaging (MRI) of brain 
revealed heterogeneous space-occupying 
lesion without perilesional edema in vermis 
and adjoining cerebellar hemisphere more 
towards left side, with a dimension of  4.4 x 4.3 
x 3.9 cm sized  causing compression of fourth 
ventricle. Which was hyperintense on T1W I 
(Fig- 2a), hypointense on T2W images 
(Figures 2b&2c) and showed mild patchy 
enhancement after injection of intravenous 
gadolinium (Figure 3). In view of feature of 
raised intracranial pressure and cerebellar 
signs and atypical radiological findings, 
patient was planned for surgery. 
He underwent midline sub occipital 
ctraniectomy in the prone position, posterior 
arch of C1 removed. After dural opening, CSF 
was released. The tumor was a grayish-yellow, 
soft,   intra-axial lesion, arising from the 
vermis. It was encapsulated    and moderately 
vascular and CUSA suckable, after securing 
hemostasis dura was closed primarily and 
wounds closed in layers. Gross total excision of 
the tumor was done. The frozen section 
showed features suggestive of 
liponeurocytoma. 
  He had an uneventful postoperative 
course and was discharged on fifth 
postoperative day. Post-op stay in the hospital 
was uneventful and his headache and vomiting 
subsided. Postoperative computerized 
tomography (CT) brain did not show any 
evidence of residual tumor. (Figure 4)   Patient 
was not advised postoperative chemotherapy 
and radiotherapy and was doing well at last 
follow-up visit six months after surgery. 
Histopathological examination of the excised 
specimen    showed a cellular lesion with 
extensive areas of lipomatous differentiation. 
The tumor was composed of round to 
polygonal cells with distinct cellular outline 
and moderate amount o cytoplasm. No 
mitosis, necrosis or endothelial proliferation 
was seen.  The tumor cells were 
immunopositive for synaptophysin, NSE, 
MAP, and negative for p53. The MIB I labeling 
index was approximately 3%. The final 
impression was liponeurocytoma of WHO 
grade II. 
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Figure 1 - Non-contrast computed tomography head 
showing hypodense lesion in midline in the posterior 
fossa causing obstructive hydrocephalus  
 
 
2a 
  
2b 2c 
Figure 2 - Magnetic Resonance images showing 
posterior fossa mass, 2a: T1-Weighted axial scan axial 
section showing hyperintense, 2b. T2-Weighted axial 
scan and 2c. T2-Weighted coronal scan showing 
hyperintense mass 
 
 
Figure 3 - Contrast-enhanced Magnetic resonance 
images showing mass in the posterior fossa with 
heterogeneous contrast enhancement 
 
 
Figure 4 - Post-operative computed tomography scan 
showing complete excision of lesion 
Discussion 
Cerebellar liponeurocytoma is an 
uncommon tumor occurring in adult age 
group in the cerebellum; it was first described 
in 1978 by Bechtel (3).   It was recognize as a 
distinct clinical entity and placed as grade II 
tumor in year 2000,    revised WHO 
classification of CNS tumors in (10). It is a rare 
tumor occurring in the posteror fossa usually 
involving cerebellar hemisphere. In a review 
carried out by de Araújo et al in 2011 reported 
a total of 32 cases including his one case report 
(6).  Different synonyms   has been used in the 
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literature to denote such tumor   lipomatous 
medulloblastoma(4, 9), loipidized 
medulloblastoma (5), and others include  
medullocytoma,     lipomatous 
glioneurocytoma  (2 )   to emphasize similarity 
to central neurocytoma and differentiate the 
prognosis from medulloblastoma. 
These tumors mostly affect adult 
population (5) and there is no gender 
predisposition (2). Patients usually presents 
with feature of cerebellar signs with raised 
intracranial pressure as pressure on fourth 
ventricle lead to obstructive hydrocephalus. 
Clinical symptoms may range s few months. 
Neurological evaluations usually show 
presence of cerebellar symptoms. 
Pathoanatomically    commonly occurs in the 
cerebellar hemispheres but may have epicentre   
in the paramedian region or even vermis (1).  
It is   typically well circumscribed but may 
show pressure effect on adjoining anatomical 
structure. With advent of blockage of CSF 
pathway can have obstructive hydrocephalus. 
On computed tomography imaging, it may 
appear    heterogeneous isodense or hypodense 
with respect to brain parenchyma with focal 
areas of marked hypodensity     like to fatty 
tissue (5). MRI is investigation of choice and 
appearance is heterogeneous caused by   
distribution and proportion of loipidized 
content, which may vary from case to case and 
even in the same lesion    On T1-weighted 
image is usually heterogeneous iso to 
hyperintense (1, 5).   On contrast 
administration, it shows   usually irregular and 
heterogeneous minimal enhancement. On T2-
weighted   slightly hyperintense to the 
surrounding brain, with focal areas of more 
pronounced hyperintensity.   Peritumoral 
oedema is may be typically absent or minimal 
(1, 5).  
The optimum mode of treatment of these 
lesions is gross total surgical excision to aid in 
diagnosis of lesion and ameliorating feature of 
raised intracranial pressure. As surgery 
provides immediate relief in headache and 
vomiting, however, controversies prevail 
regarding the ideal adjuvant therapy.   
LNC   is a neuroectodermal tumor and 
consists of both glial and neural components. 
Immunohistochemistry for GFAP, 
synaptophysin and NSE are usually positive 
showing origin of mixed glial and neuronal 
elements. Microscopically, the tumor consists 
of small,   ovoid cells with areas of    mature 
adipocytes4 resembling loipidized cells (2).   
Mitotic activity is usually absent and   MIB-1 
labeling index usually lies in the range of 1%-
3%.  Most of the available pertinent literature 
shows case reports only and there is no 
consensus yet on the optimum line of 
management of this rare entity (1, 2). 
 LNC has a relatively benign clinical course 
following surgery (7, 11).  Usually surgery is 
the treatment of choice and radiotherapy or 
chemotherapy is usually not advocated, when 
gross total excision has been carried out 
during primary surgery. In the literature 5- 
year survival has been reported to be 81%; 
however   recurrence were encountered in 20-
32% patients on an average follow-up of 10- 
years following surgical treatment (11).  
However, Jenkinson et al reported case which 
recurred 12 months following subtotal 
resection with atypical highly aggressive 
course unresponsive to radiation (8).                                            
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Kleihues    advocated avoidance of adjuvant 
therapy is if the MIB-1 index is within the range 
of 1% to 3% and no residual lesion following 
surgical decompression and such case carry    
favorable prognosis (9). There is no report of 
spinal drop metastasis and hence spinal radiation 
is not advisable (2).  Diagnosis of LNC   requires 
high index of suspicion and neuroimaging with 
typical MRI findings may be help to confirm the 
diagnosis. The tumor needs to be differentiated 
from medulloblastoma, which is far more 
common and aggressive and requires post-
operative chemo-radiation and carries poor 
prognosis (6).  
Conclusion 
Cerebellar neurocytoma is a newly 
acknowledged clinicopathological entity, very 
rare tumor.  Usually surgical excision is the 
initial mode of treatment.  In view of 
favourable prognosis with probable benign 
nature of the lesion mandates follow up 
without any adjuvant chemotherapy or 
radiotherapy following gross total surgical 
excision and, post operative scan showing no 
residual lesion and the MIB-labeling index is 
less than three percent. Preoperative 
awareness on basis of neuroimaging can lead 
to total excision and can obviate need for 
chemo-radiation adjuvant therapy.  
Neuroscientist should   differentiate it    from 
medulloblastoma, which is far more common 
in occurrence, runs much    aggressive clinical 
course with repeated recurrence even after 
post-operative chemo-radiation adjuvant 
therapy following micro-neurosurgical   
excision. 
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